Based on the one-year price targets offered by 12 analysts, the average target price for Allogene Therapeutics Inc (NASDAQ:ALLO) is $9.51 with a high estimate of $14 and a low estimate of $3.50. The ...
After two and a half years of service, Google’s Allo chat app is being closed for good on Tuesday, March 12. Google launched the chat app in September of 2016, offering a feature-rich environment for ...
Based on the one-year price targets offered by 10 analysts, the average target price for Allogene Therapeutics Inc (NASDAQ:ALLO) is $7.65, with a high estimate of $14.00 and a low estimate of $2.50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback